ArticlePediatric research2026
Ketogenic diet for pediatric drug-resistant epilepsy: sleep, children's psychosocial functioning, and maternal mental health.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite increasing attention to ketogenic dietary therapy (KDT) for drug-resistant epilepsy (DRE) in children, research examining its impact on non-seizure outcomes in children and their mothers remains limited. This study examined effects of KDT on sleep quality, children's psychosocial functioning, and maternal mental health.
methodsThis prospective study followed 40 children with DRE and their mothers from baseline to 4 and 12 weeks after KDT initiation. Children's sleep and psychosocial functioning were assessed using the Children's Sleep Habits Questionnaire and the Strengths and Difficulties Questionnaire. Maternal sleep and mental health were evaluated using the Pittsburgh Sleep Quality Index and the Depression Anxiety and Stress Scale.
resultsSignificant improvements in children's sleep and psychosocial functioning, as well as maternal sleep and mental health symptoms, were observed at 4 weeks, with the greatest improvements at 12 weeks. Regression analyses showed changes in seizure severity were associated with improvements in children's sleep and psychosocial functioning. Improved children's sleep was associated with better psychosocial outcomes. Maternal sleep quality and stress demonstrated a reciprocal relationship.
conclusionsA 12-week KDT was associated with improvements in children's sleep quality and psychosocial functioning, as well as maternal sleep quality and mental health, suggesting benefits beyond seizure control. IMPACT STATEMENT: KD has recently gained attention in pediatric drug resistant epilepsy (DRE) management, and further potential assets for patients and families should be emphasized. KD is a tolerable, safe, and effective line of therapy in pediatric DRE without significant negative impacts on the patients. The positive effect of KD on sleep and psychological function of pediatric patients, as well as mothers' mental health, are promising findings, and wider scale studies and longer KD usage can prove additional achievements in treated patients.
Identifiers
42521800What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.